×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: Advanced Proteolysis and Ubiquitin System Targeting in CBS/P
mechanism
2,062 words
KG: ent-dise-bfd8f32d
2026-03-26
section:mechanisms
kind:mechanism
topic:psp
topic:cbs
state:published
Contents
Advanced Proteolysis and Ubiquitin System Targeting in CBS/PSP
⚙
Mechanism Info
Name
Advanced Proteolysis and Ubiquitin System Targeting in CBS/PSP
Summary
Advanced Proteolysis and Ubiquitin System Targeting in CBS/PSP - comprehensive guide for CBS/PSP patients
Knowledge Graph
Related Hypotheses (22)
Purinergic Signaling Polarization Control
Score: 0.55
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
Conditional CRISPR Kill Switches for Aberrant Protein Cleara
Score: 0.45
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Blood-Brain Barrier SPM Shuttle System
Score: 0.55
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
Phase-Separated Organelle Targeting
Score: 0.52
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48
APOE-TREM2 Interaction Modulation
Score: 0.48
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.43
The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Score: 0.40
TFEB-PGC1α Mitochondrial-Lysosomal Decoupling
Score: 0.40
DNMT1-Targeting Antisense Oligonucleotide Reset
Score: 0.36
Proteostasis Enhancement via APOE Chaperone Targeting
Score: 0.50
Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro
Score: 0.49
Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar
Score: 0.48
Show 17 more
Related Analyses (30)
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Show 25 more
Related Experiments (15)
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40
Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.40
Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.40
Endothelium-specific TBK1 knockdown in atherosclerosis model
validation · proposed · Score: 0.90
iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90
TBK1-PAK1IP1-PAK1 signaling pathway analysis
exploratory · proposed · Score: 0.90
Autophagy receptor identification for stress granule elimina
exploratory · proposed · Score: 0.90
Autophagy receptor knockout effects on stress granule accumu
exploratory · proposed · Score: 0.85
LC-MS/Western blot analysis of TBK1 in atherosclerotic arter
exploratory · proposed · Score: 0.80
Show 10 more
See Also (15)
TREM2 Agonist Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses
TLR4 Antagonists for Neurodegeneration
therapeutic · Pages share 4 hypotheses
Tirzepatide and Dual GIP/GLP-1 Agonists for Neurodegene
therapeutic · Pages share 4 hypotheses
SYK Kinase Inhibitor Therapy for Neurodegeneration
therapeutic · Pages share 4 hypotheses
STING Inhibitor Therapy in Neurodegeneration
therapeutic · Pages share 4 hypotheses
Specialized Pro-Resolving Mediator (SPM) Therapy for Ne
therapeutic · Pages share 4 hypotheses
Somatostatin Receptor Modulator Therapy in Neurodegener
therapeutic · Pages share 4 hypotheses
Section 99: Purinergic Signaling and P2X/P2Y Receptors
therapeutic · Pages share 4 hypotheses
Section 217 Advanced Cell Therapy and Regenerative Medi
therapeutic · Pages share 4 hypotheses
Advanced Computational Neuroscience and AI-Driven Drug
therapeutic · Pages share 4 hypotheses
Computational Pharmacology and AI-Driven Drug Combinati
therapeutic · Pages share 4 hypotheses
Section 187: Advanced Cytokine and Chemokine Network Th
therapeutic · Pages share 4 hypotheses
Section 183: Epitranscriptomics and RNA Modifications i
therapeutic · Pages share 4 hypotheses
Advanced Neuroimmune Interface and Glial-Neuronal Cross
therapeutic · Pages share 4 hypotheses
Section 147 Neuroimmune Interface and Glial-Neuronal Cr
therapeutic · Pages share 4 hypotheses
Show 10 more